Member access

4-Traders Homepage  >  Shares  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Acuvax Ltd.    ACU   AU000000ACU7

ACUVAX LTD. (ACU)

1
End-of-day quote. End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 03/20
0.001 AUD   --.--%
SummaryQuotesChart AnalysisCompany 
Business Summary
Develops cancer treatments and drug technologies

Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America.

It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers.

The company is headquartered in West Perth, Australia.
Sales per Businesses
20122013Delta
AUD (in Million)%AUD (in Million)%
Oncology Drug R&D--0.007100%-
Sales per Regions
20122013Delta
AUD (in Million)%AUD (in Million)%
Australia--0.007100%-
North America-----
Officers and Executives
NameAgeOfficer SinceTitle
Roger Aston, PhD58-0001Executive Chairman
Paul A. Hopper582005Chief Operating Officer & Director
Roland Holger Berzins612012Secretary & Non-Executive Director
Ian Barrie Murie612010Independent Non-Executive Director
Anton Uvarov PhD, MBA-2013Non-Executive Director
Surperformance© rating of Acuvax Ltd.
Overall rating In sector In country
Trading Rating - - -
Investor Rating - - -
Growth (Revenue) - - -
Valuation - - -
Finances - - -
Profitability - - -
Earnings quality - - -
Business Predictability - - -
PER - - -
Potential - - -
Yield - - -
Consensus - - -
7 days EPS revision - - -
4 months EPS revision - - -
1 year EPS revision - - -
4 months Revenue revision - - -
1 year Revenue revision - - -
More Ratings
Advertisement
Company contact information
Acuvax Ltd.
16 Ord Street
West Perth, Western Australia (WA) 6005

Phone : +61.8.9429.2900
Fax : +61.8.9486.1011
Web : www.acuvax.com.au
© 2014 Factset   
Dynamic quotes  
ON
| OFF